Patents by Inventor Gerd Fricker

Gerd Fricker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Galenical formulations
    Patent number: 7025975
    Abstract: A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
    Type: Grant
    Filed: May 18, 2004
    Date of Patent: April 11, 2006
    Assignee: Novartis AG
    Inventors: Gerd Fricker, Barbara Haeberlin, Armin Meinzer, Jacky Vonderscher
  • Galenical formulations
    Publication number: 20040209911
    Abstract: A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
    Type: Application
    Filed: May 18, 2004
    Publication date: October 21, 2004
    Inventors: Gerd Fricker, Barbara Haeberlin, Armin Meinzer, Jacky Vonderscher
  • Bdellosomes
    Publication number: 20040062815
    Abstract: The invention relates to solid particles for transportation of pharmaceutically active substances, to processes for the preparation thereof, to medicinal drugs containing said particles, and to the use of said particles for various specific indications.
    Type: Application
    Filed: August 4, 2003
    Publication date: April 1, 2004
    Inventors: Gerd Fricker, Rudiger Marcus Flaig
  • Galenical formulations
    Publication number: 20030166517
    Abstract: A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
    Type: Application
    Filed: March 12, 2003
    Publication date: September 4, 2003
    Inventors: Gerd Fricker, Barbara Haeberlin, Armin Meinzer, Jacky Vonderscher
  • Galenical formulations
    Patent number: 6565859
    Abstract: A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: May 20, 2003
    Assignee: Novartis AG
    Inventors: Gerd Fricker, Barbara Haeberlin, Armin Meinzer, Jacky Vonderscher
  • Galenical formulations
    Patent number: 5932243
    Abstract: A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: August 3, 1999
    Assignee: Novartis AG
    Inventors: Gerd Fricker, Barbara Haeberlin, Armin Meinzer, Jacky Vonderscher